NCT00316303View on ClinicalTrials.gov

Effectiveness of the Screen, Test, Immunize, Reduce Risk, and Refer (STIRR) Intervention for People With Both a Mental and Substance Abuse Disorder

PHASE2CompletedINTERVENTIONAL

Enrollment

236

Participants

Timeline

Start Date

February 28, 2006

Primary Completion Date

April 30, 2009

Study Completion Date

August 31, 2012

Conditions

HIV InfectionsSchizophreniaSchizoaffective DisorderBipolar DisorderDepressionSubstance Abuse

Interventions

DRUG

Twinrix

This vaccine will be given in three parts: at entry and after 3 and 6 months.

BEHAVIORAL

Enhanced treatment as usual

Participants will receive comprehensive mental health services provided at each study site, education about blood-borne diseases, and referral to a local community health provider for blood testing, HAV and HBV immunizations, and any necessary treatments.

Trial Locations (1)

21201

University of Maryland, Department of Psychaitry, Baltimore

All Listed Sponsors

collaborator

National Institute of Mental Health (NIMH)

NIH

lead

Dartmouth-Hitchcock Medical Center

OTHER

NCT00316303 - Effectiveness of the Screen, Test, Immunize, Reduce Risk, and Refer (STIRR) Intervention for People With Both a Mental and Substance Abuse Disorder | Biotech Hunter | Biotech Hunter